Corrigenda

Authors: Sally B. Killick  Chris Carter  Dominic Culligan  Christopher Dalley  Emma Das‐Gupta Mark Drummond  Helen Enright  Gail L. Jones  Jonathan Kell  Juliet Mills  Ghulam Mufti Jane Parker  Kavita Raj  Alexander Sternberg  Paresh Vyas  David Bowen British Committee for Standards in Haematology

Introduction

‘Guidelines for the diagnosis and management of adult myelodysplastic syndromes’ by Sally Killick et al, British Journal of Haematology, 164:4, February 2014, 503–525. The MDS guideline committee would like to correct an error regarding cytogenetic analysis in this Guidelines article. It should read that ‘cytogenetic analysis should be performed on at least 20 metaphases and should be reported in accordance with the International System Recommendations’.

Read or download here

IPSS-R MDS Risk Assessment Calculator

Revised International Prognostic Scoring System (IPSS-R) for Myelodysplastic Syndromes Risk Assessment Calculator

calculator

Click here

MDS Fact Sheet

MDS Factsheet for GPs General Practicioners

calculator

Click here

Varicella Vaccine in MDS

Urgent Clarification on varicella vaccine policy

Current advice from the UK MDS Forum is not to give the Live Varicella Vaccine to patients with MDS.

Please read below correspondence between Professor Salisbury and Dr George Follows, the latter on behalf of the CLL Forum, on the varicella vaccine policy.
This is an external link to the British Society for Haematology  Click here

NICE Guideline

Lenalidomide for treating myelodysplastic syndromes (MDS) associated with an isolated deletion 5q cytogenetic abnormality.

NICE logo

Click here

BCSH Guideline

This is an external  link to the home of the British Society for Haematology (BSH). 

bsh logo

Click here